united nations international childrens emergency fund: Live & Latest News Updates : Vimarsana.com
Updated Apr 12, 2021 | 12:19 IST
International Day for Street Children 2021: India is home to one of the planet's largest population of Street Children and the situation is alarming. Street dwellers keeping warm by burning fire on a winter morning near Howrah Bridge in Kolkata. (File Pic)  |  Photo Credit: iStock Images
They're often described as 'invisible'. But anyone rushing through the busy roads of any metro cities in India could hardly help not noticing that child hawker pleading desperately to sell a sunshade, a packet of tissue paper, or something that is of minimal importance. We often ignore their presence and ensconce the private luxury of our vehicles cursing the traffic signal.
LucknowUttar-pradeshIndiaMughalsaraiMumbaiMaharashtraAllahabadPuneKolkataWest-bengalKanpurDelhiCOVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate.Aurobindo Pharma and US-based COVAXX have entered into an exclusive license agreement to develop, commercialize and manufacture UB-612, the first multitope peptide-based vaccine to fight COVID-19, for India and the United Nations Children's Fund (UNICEF) agency.
Under the signed agreement, Aurobindo Pharma has obtained the exclusive rights to develop, manufacture and sell COVAXX's UB-612 vaccine in India and to UNICEF, as well as non-exclusive rights in other select emerging and developing markets.
Aurobindo Pharma and COVAXX are partnering on clinical development, manufacturing and marketing of COVAXX's vaccine candidate, UB-612. The pharmaceutical company will manufacture the finished doses at its facilities in Hyderabad (Telangana). Aurobindo Pharma has the capacity of manufacturing 220 million doses in multi-dose presentation and is building additional facilities to have a total capacity of nearly 480 million doses by June 2021, the company said in a statement before market hours today, 24 December 2020.
IndiaAurobindo-pharmaUnited-nations-children-fundUnited-nations-childrenCapital-marketMedicineVaccinesHealth-sciencesVaccinationMedical-researchZika-virusZika-virus-vaccine